1. Report Overview

1.1 Global Pharma Clinical Trial Services Market Overview

1.2 Why You Should Read This Report

1.3 Key Questions Answered by This Analytical Report

1.4 Structure of the Report

1.5 Who is This Report For?

1.6 Methodology

1.7 Frequently Asked Questions (FAQ)

1.8 Associated Visiongain Reports

1.9 About Visiongain

2. Pharma Clinical Trial Services Market Introduction

2.1 Clinical Trials: A Historical Perspective

2.2 Design and Execution of Clinical Trials

2.3 Phases of Clinical Trials

2.3.1 Phase I Trials: First In-Human Studies

2.3.2 Phase II Trials: Proof-of- Concept

2.3.3 Phase III Trials: Drug Approval Applications

2.3.4 Post-Marketing Studies

2.3.5 Key Elements of Clinical Trials

2.4 Common Trial Designs

2.4.1 Improving Clinical Trial Models through Adaptive Trial Designs

2.5 Clinical Trial Outsourcing

2.5.1 Challenges Exist in Conducting Clinical Trials

2.5.2 Benefits of Outsourcing

3. Pharma Clinical Trial Services: World Market by Services 2020-2030

3.1 The Impact of Economy on the Clinical Trial Services Market 2019-2030

3.2 Pharma Clinical Trial Services Market by Services 2019-2030

3.2.1 Early Phase Clinical Trial Services Market Forecasts 2019-2030

3.2.2 Late Phase Clinical Trial Services Market Forecasts 2019-2030

3.2.3 Other Clinical Trial Services Market Forecasts 2019-2030



4. Pharma Clinical Trial Services: World Market by End-Users 2019-2030

4.1 The Evolution of the Clinical Research Organizations (CROs)

4.2 Pharma Clinical Trial Services Market, by End-Users 2019-2030

4.2.1 Clinical Trial Services Market by Pharma End-Users Forecasts 2019-2030

4.2.2 Clinical Trial Services Market by Biotech Companies End-Users Forecasts 2019-2030

4.2.3 Clinical Trial Services Market by Other End-Users Forecasts 2019-2030

5. Pharma Clinical Trial Services: World Market by Therapeutic Areas 2019-2030

5.1 Rise of Clinical Trial Services in Key Therapeutic Areas

5.1.1 Cancer Clinical Trial Services Market Forecasts 2019-2030

5.1.2 Cardiovascular Diseases Clinical Trial Services Market Forecasts 2019-2030

5.1.3 CNS Diseases Clinical Trial Services Market Forecasts 2019-2030

5.1.4 Infectious Diseases Clinical Trial Services Market Forecasts 2019-2030

5.1.5 Metabolic Diseases Clinical Trial Services Market Forecasts 2019-2030

5.1.6 Other Diseases Clinical Trial Services Market Forecasts 2019-2030

6. Regional Pharma Clinical Trial Services Market Forecasts 2019-2030

6.1 North American Pharma Clinical Trial Services Market Forecasts 2019-2030

6.1.1 U.S. Pharma Clinical Trial Services Market Forecasts 2019-2030

6.1.2 Rest of North America Pharma Clinical Trial Services Market Forecasts 2019-2030

6.2 North American Pharma Clinical Trial Services Market Forecasts by Service 2019-2030

6.3 North American Pharma Clinical Trial Services Market Forecasts by Therapeutic Area 2019-2030

6.4 North American Pharma Clinical Trial Services Market Forecasts by End-Users 2019-2030

6.5 Europe Pharma Clinical Trial Services Market Forecasts 2019-2030

6.5.1 France Pharma Clinical Trial Services Market Forecasts 2019-2030

6.5.2 Germany Pharma Clinical Trial Services Market Forecasts 2019-2030

6.5.3 U.K. Pharma Clinical Trial Services Market Forecasts 2019-2030

6.5.4 Spain Pharma Clinical Trial Services Market Forecasts 2019-2030

6.5.5 Italy Pharma Clinical Trial Services Market Forecasts 2019-2030

6.5.6 Russia Pharma Clinical Trial Services Market Forecasts 2019-2030

6.5.7 Central and Eastern Europe Pharma Clinical Trial Services Market Forecasts 2019-2030

6.5.8 Rest of Europe Pharma Clinical Trial Services Market Forecasts 2019-2030

6.6 European Pharma Clinical Trial Services Market Forecasts by Service 2019-2030

6.7 European Pharma Clinical Trial Services Market Forecasts by Therapeutic Area 2019-2030

6.8 European Pharma Clinical Trial Services Market Forecasts by End-Users 2019-2030

6.9 Asia-Pacific Pharma Clinical Trial Services Market Forecasts 2019-2030

6.9.1 China Pharma Clinical Trial Services Market Forecasts 2019-2030

6.9.2 India Pharma Clinical Trial Services Market Forecasts 2019-2030

6.9.3 Japan Pharma Clinical Trial Services Market Forecasts 2019-2030

6.9.4 South Korea Pharma Clinical Trial Services Market Forecasts 2019-2030

6.9.5 Rest of Asia-Pacific (APAC) Pharma Clinical Trial Services Market Forecasts 2019-2030

6.10 Asia-Pacific Pharma Clinical Trial Services Market Forecasts by Service 2019-2030

6.11 Asia-Pacific Pharma Clinical Trial Services Market Forecasts by Therapeutic Area 2019-2030

6.12 Asia-Pacific Pharma Clinical Trial Services Market Forecasts by End-Users 2019-2030

6.13 Rest of the World (RoW) Pharma Clinical Trial Services Market Forecasts 2019-2030

6.13.1 Latin America Pharma Clinical Trial Services Market Forecasts 2019-2030

6.13.2 Middle East and Africa Pharma Clinical Trial Services Market Forecasts 2019-2030

6.13.3 Brazil Pharma Clinical Trial Services Market Forecasts 2019-2030

6.14 Rest of the World (RoW) Pharma Clinical Trial Services Market Forecasts by Service 2019-2030

6.15 Rest of the World (RoW) Pharma Clinical Trial Services Market Forecasts by Therapeutic Area 2019-2030

6.16 Rest of the World (RoW) Pharma Clinical Trial Services Market Forecasts by End-Users 2019-2030

7. Drivers & Restraints

7.1 Drivers and Restraints 2019-2030

7.2 Drivers

7.2.1 Rising Demand of Clinical Trials Worldwide

7.2.2 Increased research and development by biopharmaceutical companies leading to better utilization of clinical trial services

7.2.3 Contract research organizations present in the emerging markets to gain major foothold in the forecast period

7.2.4 Growth of biopharma R&D expenditures will lead to increase in the clinical trial market

7.2.5 Emerging markets especially China becoming a much sought-after clinical trial destination

7.2.6 Increased Strategic Alliances among Large BioPharma Companies and CROs benefitting the market

7.3 Restraints

7.3.1 Regulatory Constraints such as longer approval time for clinical trials

7.3.2 Poor Physician and Nurse Engagement Leading to Low Patient Recruitment Rates

7.4 Challenges

7.4.1 High cost

8. Leading Companies in the Pharma Clinical Trial Services Market

8.1 Quintiles IMS Holdings Inc.

8.1.1 Quintiles IMS Holdings Inc. Business Overview

8.1.2 Quintiles IMS Holdings Inc. Financial Overview

8.1.3 Quintiles IMS Holdings Inc. Corporate Strategy

8.2 LabCorp (Covance Inc.)

8.2.1 LabCorp Business Overview

8.2.2 LabCorp Financial Overview

8.2.3 LabCorp (Covance Inc.) Corporate Strategy

8.3 Pharmaceutical Product Development (PPD), LLC

8.3.1 Pharmaceutical Product Development (PPD) Business Overview

8.3.2 Pharmaceutical Product Development (PPD) Financial Overview

8.3.3 Pharmaceutical Product Development (PPD) Corporate Strategy

8.4 Parexel International Corporation

8.4.1 Parexel International Corporation Business Overview

8.4.2 Parexel International Corporation Financial Overview

8.4.3 Parexel International Corporation Corporate Strategy

8.5 ICON

8.5.1 ICON Business Overview

8.5.2 ICON Financial Overview

8.5.3 ICON Corporate Strategy

8.6 INC Research

8.6.1 INC Research Business Overview

8.6.2 INC Research Financial Overview

8.6.3 INC Research Corporate Strategy

8.7 inVentiv Health

8.7.1 inVentiv Health Business Overview

8.7.2 inVentiv Health Financial Overview

8.7.3 inVentiv Health Corporate Strategy

8.8 PRA Health Sciences

8.8.1 PRA Health Sciences Business Overview

8.8.2 PRA Health Sciences Financial Overview

8.8.3 PRA Health Sciences Corporate Strategy

8.9 Chiltern International

8.9.1 Chiltern International Business Overview

8.9.2 Chiltern International Financial Overview

8.9.3 Chiltern International Corporate Strategy

8.10 Charles River Laboratories

8.10.1 Charles River Laboratories Business Overview

8.10.2 Charles River Laboratories Financial Overview

8.10.3 Charles River Laboratories Corporate Strategy

8.11 Wuxi AppTec

8.11.1 Wuxi AppTec Business Overview

8.11.2 Wuxi AppTec Financial Overview

8.11.3 Wuxi AppTec Corporate Strategy

8.12 Almac Group

8.12.1 Wuxi AppTec Business Overview

8.12.2 Wuxi AppTec Corporate Strategy

8.13 Ancillare, LP

8.13.1 Ancillare, LP Business Overview

8.13.2 Ancillare, LP Corporate Strategy

8.14 KLIFO

8.14.1 KLIFO Business Overview

8.15 Catalent, Inc

8.15.1 Catalent, Inc Business Overview

8.15.2 Catalent, Inc Corporate Strategy

8.16 Covance Inc

8.16.1 Covance Inc Business Overview

9. STEP Analysis of the Pharma Clinical Trial Services Market 2019-2030

9.1 STEP Analysis of the Pharma Clinical Trial Services Market

9.2 Social Factors Affecting Clinical Trials

9.2.1 Ethical Considerations in Conducting Clinical Trials

9.2.2 Patient Recruitment: Major Challenge in Developed Markets

9.3 Technological Development for Improved Trials

9.3.1 Electronic Data Capture

9.3.2 eClinical Trial Tools

9.3.3 Use of Electronic Health Records for Faster Patient Recruitment

9.3.4 Cloud Computing used as a Tool for Multicentre Trials

9.4 Economic Considerations for Clinical Trial Outsourcing

9.4.1 Pharma is adjusting its R&D strategies

9.4.2 CROs tend to be attractive for Private Investigators

9.5 Political and Regulatory Considerations for Clinical Trial Outsourcing

9.5.1 Drug Safety and Clinical Trials Post-Approval

9.5.2 Cutting Red Tape and Other Regulatory Developments

10. Conclusions

10.1 Current Leading Pharma Clinical Trial Services Market Segments

10.1.1 Leading Contract Research Organizations

10.1.2 Leading Regional Markets

10.1.3 Emerging Pharma Clinical Trial Services Markets

Glossary

Associated Visiongain Reports

Visiongain Report Sales Order Form

Appendix A

About Visiongain

Appendix B

Visiongain report evaluation form

List of Tables

Table 2.1 Founding Members of the ICH

Table 2.2 Types of Adaptive Trial Design

Table 3.1 Breakdown of Pharma Clinical Spending by Phase, 2014

Table 3.2 Breakdown of Pharma Clinical Trial Services by Phase

Table 3.3 Pharma Clinical Trial Services Market by Service: Forecast ($bn, AGR%, CAGR%), 2019-2030

Table 3.4 Early Phase Clinical Trial Services Market by Region: Forecast ($bn, AGR%, CAGR%), 2019-2030

Table 3.5 Late Phase Clinical Trial Services Market by Region: Forecast ($bn, AGR%, CAGR%) 2019-2030

Table 3.6 Other Pharma Clinical Trial Services Markets by Region: Forecast ($bn, AGR%, CAGR%) 2019-2030

Table 4.1 Pharma Clinical Trial Services Submarket by End-Users: Forecast ($bn, AGR%, CAGR%), 2019-2030

Table 4.2 Clinical Trial Services Pharma Submarket by Region: Forecast ($bn, AGR%, CAGR%), 2019-2030

Table 4.3 Clinical Trial Services Biotech Companies Submarket by Region: Forecast ($bn, AGR%, CAGR%) 2019-2030

Table 4.4 Clinical Trial Services Other End-Users Submarket by Region: Forecasts ($bn, AGR%, CAGR%), 2019-2030

Table 5.1 Pharma Clinical Trial Services Submarkets by Therapeutic Area: Forecast ($bn, AGR %, CAGR%), 2019-2030

Table 5.2 Cancer Clinical Trial Services Market by Region: Forecast ($bn, AGR%, CAGR%), 2019-2030

Table 5.3 Cardiovascular Diseases Clinical Trial Services Market by Region: Forecast ($bn, AGR%, CAGR%), 2019-2030

Table 5.4 CNS Diseases Clinical Trial Services Market by Region: Forecast ($bn, AGR%, CAGR%), 2019-2030

Table 5.5 Infectious Diseases Clinical Trial Services Market by Region: Forecast ($bn, AGR%, CAGR%), 2019-2030

Table 5.6 Metabolic Diseases Clinical Trial Services Market by Region: Forecast ($bn, AGR%, CAGR%), 2019-2030

Table 5.7 Other Diseases Clinical Trial Services Market by Region: Forecast ($bn, AGR%, CAGR%), 2019-2030

Table 6.1 Regional Pharma Clinical Trial Services Market: Forecast ($bn, AGR% CAGR%), 2019-2030

Table 6.2 U.S. Pharma Clinical Trial Services Market: Forecast ($bn, AGR% CAGR%, 2019-2030

Table 6.3 Rest of North America Pharma Clinical Trial Services Market: Forecast ($bn, AGR% CAGR%), 2019-2030

Table 6.4 North American Pharma Clinical Trial Services Market by Service: Forecast ($bn, AGR% CAGR%), 2019-2030

Table 6.5 North American Pharma Clinical Trial Services Market by Therapeutic Area: Forecast ($bn, AGR% CAGR%), 2019-2030

Table 6.6 North American Pharma Clinical Trial Services Market by End-Users: Forecast ($bn, AGR% CAGR%), 2019-2030

Table 6.7 France Pharma Clinical Trial Services Market: Forecast ($bn, AGR% CAGR%), 2019-2030

Table 6.8 Germany Pharma Clinical Trial Services Market: Forecasts ($bn, AGR% CAGR%), 2019-2030

Table 6.9 U.K. Pharma Clinical Trial Services Market: Forecasts ($bn, AGR% CAGR%), 2019-2030

Table 6.10 Spain Pharma Clinical Trial Services Market: Forecasts ($bn, AGR% CAGR%), 2019-2030

Table 6.11 Italy Pharma Clinical Trial Services Market: Forecasts ($bn, AGR% CAGR%), 2019-2030

Table 6.12 Russia Pharma Clinical Trial Services Market: Forecasts ($bn, AGR% CAGR%), 2019-2030

Table 6.13 Central and Eastern Europe (CEE) Pharma Clinical Trial Services Market: Forecasts ($bn, AGR% CAGR%), 2019-2030

Table 6.14 Rest of Europe Pharma Clinical Trial Services Market: Forecasts ($bn, AGR% CAGR%), 2019-2030

Table 6.15 European Pharma Clinical Trial Services Market by Service: Forecast ($bn, AGR% CAGR%), 2019-2030

Table 6.16 European Pharma Clinical Trial Services Market by Therapeutic Area: Forecast ($bn, AGR% CAGR%), 2019-2030

Table 6.17 European Pharma Clinical Trial Services Market by End-Users: Forecast ($bn, AGR% CAGR%), 2019-2030

Table 6.18 China Pharma Clinical Trial Services Market: Forecasts ($bn, AGR% CAGR%), 2019-2030

Table 6.19 India Pharma Clinical Trial Services Market: Forecasts ($bn, AGR% CAGR%), 2019-2030

Table 6.20 Japan Pharma Clinical Trial Services Market: Forecasts ($bn, AGR% CAGR%), 2019-2030

Table 6.21 South Korea Pharma Clinical Trial Services Market: Forecasts ($bn, AGR% CAGR%), 2019-2030

Table 6.22 Rest of Asia-Pacific (APAC) Pharma Clinical Trial Services Market: Forecasts ($bn, AGR% CAGR%), 2019-2030

Table 6.23 Asia-Pacific Pharma Clinical Trial Services Market by Service: Forecast ($bn, AGR% CAGR%), 2019-2030

Table 6.24 Asia-Pacific Pharma Clinical Trial Services Market by Therapeutic Area: Forecast ($bn, AGR% CAGR%), 2019-2030

Table 6.25 Asia-Pacific Pharma Clinical Trial Services Market by End-Users: Forecast ($bn, AGR% CAGR%), 2019-2030

Table 6.26 Latin America Pharma Clinical Trial Services Market: Forecasts ($bn, AGR% CAGR%), 2019-2030

Table 6.27 Middle East and Africa Pharma Clinical Trial Services Market: Forecasts ($bn, AGR% CAGR%), 2019-2030

Table 6.28 Brazil Pharma Clinical Trial Services Market: Forecasts ($bn, AGR% CAGR%), 2019-2030

Table 6.29 RoW Pharma Clinical Trial Services Market by Service: Forecast ($bn, AGR% CAGR%), 2019-2030

Table 6.30 RoW Pharma Clinical Trial Services Market by Therapeutic Area: Forecast ($bn, AGR% CAGR%), 2019-2030

Table 6.31 RoW Pharma Clinical Trial Services Market by End-Users: Forecast ($bn, AGR% CAGR%), 2019-2030

Table 9.1 STEP Analysis of Pharma Clinical Trial Services Market 2019-2030

List of Figures

Figure 2.1 Brief History of Clinical Trials

Figure 3.1 Breakdown of Pharma Clinical Spending by Phase

Figure 3.2 Global Pharma Clinical Trial Services Market by Service: (% Share), 2020

Figure 3.3 Global Pharma Clinical Trial Services Market by Service: (% Share), 2025

Figure 3.4 Global Pharma Clinical Trial Services Market by Service: (% Share), 2030

Figure 3.5 Pharma Clinical Trial Services Market by Services: Revenue ($bn), 2019-2030

Figure 3.6 Early Phase Services Market Forecasts: Revenue, $Bn 2019-2030

Figure 3.7 Global Early Phase Clinical Trial Services Market by Region: Revenue ($bn), 2019-2030

Figure 3.8 Global Early Phase Clinical Trial Services by Region: (% Share), 2019-2030

Figure 3.9 Late Phase Clinical Trial Services Market Forecasts: Revenue, $Bn 2019-2030

Figure 3.10 Global Late Phase Clinical Trial Services Market by Region: Revenue ($bn), 2019-2030

Figure 3.11 Global Late Phase Clinical Trial Services by Region: (% Share,) 2019-2030

Figure 3.12 Other Pharma Clinical Trial Services Market Forecasts: $bn 2019-2030

Figure 3.13 Global Other Pharma Clinical Trial Services Market by Region, 2019-2030

Figure 3.14 Global Other Pharma Clinical Trial Services Market Share, by Region, (% Share) 2019-2030

Figure 4.1 Pharma Clinical Trial Services Submarkets by End-Users: Revenue ($bn), 2019-2030

Figure 4.2 Clinical Trial Services Pharma Submarket: AGR (%), 2020-2030

Figure 4.3 Global Clinical Trial Services Pharma Submarket by Region: Revenue ($bn), 2019-2030

Figure 4.4 Global Clinical Trial Services Pharma Submarket by Region: (% Share), 2019-2030

Figure 4.5 Clinical Trial Services Biotech Submarket: AGR (%), 2020-2030

Figure 4.6 Global Clinical Trial Services Biotech Companies Submarket by Region: Revenue ($bn), 2019-2030

Figure 4.7 Global Clinical Trial Services Biotech Companies Submarket by Region: (% Share), 2019-2030

Figure 4.8 Clinical Trial Services Other End-Users Submarket: AGR (%), 2020-2030

Figure 4.9 Global Clinical Trial Services Other End-Users Submarket by Region: Revenue ($bn), 2019-2030

Figure 4.10 Global Clinical Trial Services Other End-Users Submarket by Region: (% Share), 2019-2030

Figure 5.1 Global Pharma Clinical Trial Services Market by Therapeutic Areas: (% Share), 2020

Figure 5.2 Global Pharma Clinical Trial Services Market by Therapeutic Areas: (% Share), 2025

Figure 5.3 Global Pharma Clinical Trial Services Market by Therapeutic Areas: (% Share), 2030

Figure 5.4 Pharma Clinical Trial Services Submarkets by Therapeutic Area: Revenue ($bn), 2019-2030

Figure 5.5 Cancer Clinical Trial Services Submarket: AGR (%), 2020-2030

Figure 5.6 Global Cancer Clinical Trial Services Submarket by Region: Revenue ($bn), 2019-2030

Figure 5.7 Global Cancer Clinical Trial Services Submarket by Region: (% Share), 2019-2030

Figure 5.8 Cardiovascular Diseases Clinical Trial Services Submarket: AGR (%), 2020-2030

Figure 5.9 Global Cardiovascular Diseases Clinical Trial Services Submarket by Region: Revenue ($bn), 2019-2030

Figure 5.10 Global Cardiovascular Diseases Clinical Trial Services Submarket by Region: (% Share), 2019-2030

Figure 5.11 CNS Diseases Clinical Trial Services Submarket: AGR (%), 2020-2030

Figure 5.12 Global CNS Diseases Clinical Trial Services Submarket by Region: Revenue ($bn), 2019-2030

Figure 5.13 Global CNS Diseases Clinical Trial Services Submarket by Region: (% Share), 2019-2030

Figure 5.14 Infectious Diseases Clinical Trial Services Submarket: AGR (%), 2020-2030

Figure 5.15 Global Infectious Diseases Clinical Trial Services Submarket by Region: Revenue ($bn), 2019-2030

Figure 5.16 Global Infectious Diseases Clinical Trial Services Submarket by Region: (% Share), 2019-2030

Figure 5.17 Metabolic Diseases Clinical Trial Services Submarket: AGR (%), 2020-2030

Figure 5.18 Global Metabolic Diseases Clinical Trial Services Submarket by Region: Revenue ($bn), 2019-2030

Figure 5.19 Global Metabolic Diseases Clinical Trial Services Submarket by Region: (% Share), 2019-2030

Figure 5.20 Other Diseases Clinical Trial Services Submarket: AGR (%), 2020-2030

Figure 5.21 Global Other Diseases Clinical Trial Services Submarket by Region: Revenue ($bn), 2019-2030

Figure 5.22 Global Other Diseases Clinical Trial Services Submarket by Region: (% Share), 2019-2030

Figure 6.1 Regional Pharma Clinical Trial Services Market: Revenue($bn), 2019-2030

Figure 6.2 North American Pharma Clinical Trial Services by Country: (% Share), 2020

Figure 6.3 North American Pharma Clinical Trial Services by Country: (% Share), 2025

Figure 6.4 North American Pharma Clinical Trial Services by Country: (% Share), 2030

Figure 6.5 U.S. Pharma Clinical Trial Services Market: Revenue ($bn), 2019-2030

Figure 6.6 Rest of North America Pharma Clinical Trial Services Market: Revenue ($bn), 2019-2030

Figure 6.7 North American Pharma Clinical Trial Services by Service: Revenue ($bn), 2019-2030

Figure 6.8 North American Pharma Clinical Trial Services Market by Therapeutic Area: Revenue ($bn), 2019-2030

Figure 6.9 North American Pharma Clinical Trial Services Market by End-Users: Revenue ($bn), 2019-2030

Figure 6.10 European Pharma Clinical Trial Services by Country (% Share), 2020

Figure 6.11 European Pharma Clinical Trial Services by Country (% Share), 2025

Figure 6.12 European Pharma Clinical Trial Services by Country (% Share), 2030

Figure 6.13 France Pharma Clinical Trial Services Market: Revenue($bn), 2019-2030

Figure 6.14 Germany Pharma Clinical Trial Services Market: Revenue($bn), 2019-2030

Figure 6.15 U.K. Pharma Clinical Trial Services Market: Revenue($bn), 2019-2030

Figure 6.16 Spain Pharma Clinical Trial Services Market: Revenue($bn), 2019-2030

Figure 6.17 Italy Pharma Clinical Trial Services Market: Revenue ($bn), 2019-2030

Figure 6.18 Russia Pharma Clinical Trial Services Market: Revenue ($bn), 2019-2030

Figure 6.19 Central and Eastern Europe (CEE) Pharma Clinical Trial Services Market: Revenue ($bn), 2019-2030

Figure 6.20 Rest of Europe Pharma Clinical Trial Services Market: Revenue ($bn), 2019-2030

Figure 6.21 European Pharma Clinical Trial Services Market by Service: Revenue ($bn), 2019-2030

Figure 6.22 European Pharma Clinical Trial Services Market by Therapeutic Area: Revenue ($bn), 2019-2030

Figure 6.23 European Pharma Clinical Trial Services Market by End-users: Revenue ($bn), 2019-2030

Figure 6.24 Asia-Pacific Pharma Clinical Trial Services by Country: (% Share), 2020

Figure 6.25 Asia-Pacific Pharma Clinical Trial Services by Country: (% Share), 2025

Figure 6.26 Asia-Pacific Pharma Clinical Trial Services by Country: (% Share), 2030

Figure 6.27 China Pharma Clinical Trial Services Market: Revenue ($bn), 2019-2030

Figure 6.28 India Pharma Clinical Trial Services Market: Revenue ($bn), 2019-2030

Figure 6.29 Japan Pharma Clinical Trial Services Market: Revenue ($bn), 2019-2030

Figure 6.30 South Korea Pharma Clinical Trial Services Market: Revenue ($bn), 2019-2030

Figure 6.31 Rest of Asia-Pacific (APAC) Pharma Clinical Trial Services Market: Revenue ($bn), 2019-2030

Figure 6.32 Asia-Pacific Pharma Clinical Trial Services Market by Service: Revenue ($bn), 2019-2030

Figure 6.33 Asia-Pacific Pharma Clinical Trial Services Market by Therapeutic Area: Revenue ($bn), 2019-2030

Figure 6.34 Asia-Pacific Pharma Clinical Trial Services Market by End-Users: Revenue($bn), 2019-2030

Figure 6.35 Rest of the World (RoW) Pharma Clinical Trial Services Market by Country (% Share), 2020

Figure 6.36 Rest of the World (RoW) Pharma Clinical Trial Services Market by Country (% Share), 2025

Figure 6.37 Rest of the World (RoW) Pharma Clinical Trial Services Market by Country (% Share), 2030

Figure 6.38 Latin America Pharma Clinical Trial Services Market: Revenue ($bn), 2019-2030

Figure 6.39 Middle East and Africa Pharma Clinical Trial Services Market: Revenue($bn), 2019-2030

Figure 6.40 Brazil Pharma Clinical Trial Services Market: Revenue($bn), 2019-2030

Figure 6.41 RoW Pharma Clinical Trial Services Market by Service: Revenue ($bn), 2019-2030

Figure 6.42 RoW Pharma Clinical Trial Services Market by Therapeutic Area: Revenue ($bn), 2019-2030

Figure 6.43 RoW Pharma Clinical Trial Services Market by End-Users: Revenue ($bn), 2019-2030

Figure 7.1 Market: Drivers and Restraints, 2019-2030

Figure 7.2 Trial Participants by Year Approved, Therapeutic Area, and Geography

Figure 7.3 China’s Trial Initiations from 2007 to 2016

Figure 8.1 Quintiles IMS Holdings Inc. 2018 Annual Revenue by Business Segment: (% Share)

Figure 8.2 Quintiles IMS Holdings Inc. Annual Revenue 2016-2018 ($mn)

Figure 8.3 LabCorp (Covance Inc.) 2018 Annual Revenue by Business Segment: (% Share)

Figure 8.4 LabCorp Annual Revenue 2016-2018 ($bn)

Figure 8.5 Pharmaceutical Product Development (PPD) 2010 Annual Revenue by Business Segment: (% Share)

Figure 8.6 Parexel International Corporation 2017 Annual Revenue by Business Segment: (% Share)

Figure 8.7 Parexel International Corporation Annual Revenue 2016-2018 ($mn)

Figure 8.8 ICON Annual Revenue 2016-2018 ($mn)

Figure 8.9 INC Research 2016 Annual Revenue by Business Segment: (% Share)

Figure 8.10 INC Research Annual Revenue 2012-2016 ($bn)

Figure 8.11 PRA Health Sciences 2017 Annual Revenue by Business Segment: (% Share)

Figure 8.12 PRA Health Sciences Annual Revenue 2016-2018 ($mn)

Figure 8.13 Charles River Laboratories 2018 Annual Revenue by Business Segment: (% Share)

Figure 8.14 Charles River Laboratories Annual Revenue 2016-2018 ($mn)

Figure 8.15 Wuxi AppTec Annual Revenue 2016-2018 ($mn)

Figure 10.1 Global Pharma Clinical Trial Services Market: Revenue($bn), 2019-2030

Figure 10.2 Pharma Clinical Trial Services Market by Region: Revenue ($bn), 2019-2030